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Abstract
Technologies designed to allow manipulation and modification of human embryonic stem (hES)
cells are numerous and vary in the complexity of their methods, efficiency, reliability, and safety.
The most commonly studied and practiced of these methods include electroporation, lipofection,
nucleofection, and lentiviral transduction. However, at present, it is unclear which protocol offers
the most efficient and reliable method of gene transfer to hES cells. In this study, a bi-fusion
construct with ubiquitin promoter driving enhanced green fluorescent protein reporter and the
firefly luciferase (pUb-eGFP-Fluc) along with neomycin selection marker was used for in vitro
and in vivo studies. In vitro studies examined the transfection efficiency and viability of each
technique using two hES cell lines (male H1 and female H9 cells). Lentiviral transduction
demonstrated the highest efficiency (H1: 25.3±4.8%; H9: 22.4±6.5%) with >95% cell viability.
Nucleofection demonstrated transfection efficiency of 16.1±3.6% (H1) and 5.8±3.2% (H9).
However, minimal transfection efficiency was observed with electroporation (2.1±0.4% (H1) and
1.9±0.3% (H9)) and lipofection (1.5±0.5% (H1) and 1.3±0.2% (H9); PG0.05 vs. lentiviral
transduction). Electroporation also demonstrated the highest cell death (62±11% (H1) and 42±
10% (H9)) followed by nucleofection (25±9% (H1) and 30±15 (H9)). Importantly, lentiviral
transduction generated a greater number of hES cell lines stably expressing the double-fusion
reporter gene (hES-DF) compared to other transfection techniques. Finally, following subcuta-
neous transplantation into immunodeficient nude mice, the hES-eGFP-Fluc cells showed robust
proliferation as determined by longitudinal bioluminescence imaging. In summary, this study
demonstrates that lentiviral transduction and nucleofection are efficient, simple, and safe
techniques for reliable gene transfer in hES cells. The double-fusion construct provides an
attractive approach for generating stable hES cell lines and monitoring engraftment and
proliferation in vitro and in vivo.
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Introduction
T
he study of embryonic stem (ES) cells will continue to
yield important discoveries in the areas of cell differen- Correspondence to: Joseph C. Wu; e-mail: joewu@stanford.edutiation and growth, tissue engineering, and regenerative
medicine. The ES cells are derived from the inner cell mass
of blastocyst embryos, have unlimited proliferation, and are
the precursor to the three embryonic germ layers [1, 2]. To
efficiently study ES cells and successfully expand their
potential clinical applications, a rapid, reliable, and simple
technique is needed to deliver genes to stem cells. Typically,
gene delivery techniques have been divided into two
categories: viral and non-viral gene delivery. Viral delivery
uses the backbone of a viral genome, such as retrovirus,
lentivirus, adenovirus, and adeno-associated virus (AAV),
with insertion of the gene(s) of interest to be expressed in the
stem cell. The more commonly used non-viral plasmid
delivery systems include liposome, electroporation, and
nucleofection-based, though newer techniques such as
ultrasound [3, 4], microinjection [5], nuclear transfer [6, 7],
and molecular-vibration-mediated delivery [8] have also
been examined, among other techniques.
The advantages of using non-viral delivery compared to
viral vector delivery include decreased immunogenicity and
less insertional mutagenesis. However, the disadvantages of
non-viral delivery may include decreased transfection
efficiency and a shorter period of transgene expression
which may limit long-term studies. For example, the
transfection efficiency and viability of hES cells following
electroporation has been shown to vary depending on the
specific voltage and capacity settings [9, 10]. Cell survival
rates following electroporation are typically low at 24 to 48 h
and often not recorded, though range from >60% at 1 to 2 h
[9], 73% at 2 to 3 h [11], to a median rate of 19% at 48 h [12].
In addition, the efficiency of gene transfer with cationic
liposomes varies significantly based on the commercial
preparation [13]. Liposome preparations may have different
aliphatic chain lengths and structural compositions, as well as
various associated anions. Nucleofection, a liposomal-based
electroporation system that can be adapted with appropriate
buffers for different cell lines, has demonstrated a significantly
higher level of transfection efficiency, with results of 32% to
66% ofviableH9.2cells at24h[11] and20% to22% ofviable
H1 cells at 72 h [14]. The survival rate following nucleofection
has been demonstrated at 74% with a control transfection at
48 h and 50% with transfection of GFP at 48 h [15]. Lastly,
despite the disadvantages associated with the use of viral
vectors for gene transfer, the lentiviral systems have reliably
demonstrated efficient transduction into hES cells. Lentiviral
transduction has demonstrated efficiencies of 20% at low viral
titers to >80% at high viral titer [16, 17].
Although various studies have examined the gene-transfer
efficiency to hES cells in vitro as highlighted above, few have
focused on a direct comparison of these techniques. In this
study, we examine lipofection, electroporation, nucleofection,
and lentiviral transduction of H1 and H9 hES cell lines to
identify the most efficient, reliable, and simple gene-transfer
system for in vitro and in vivo applications. Using a double-
fusion plasmid construct expressing eGFP and Fluc, the
transfection efficiency was carefully demonstrated for each
protocol. Stable cell lines expressing the bi-fusion construct
were generated by lentiviral transduction and nucleofection.
Variouswell-characterizedstemcellmarkers,includingSSEA-
4andOct4,wereassayedtoensurethatthehEScellscontinued
to express the appropriate markers following treatment.
Finally, bioluminescence imaging was used to facilitate non-
invasive monitoring of transplanted hES cells in vivo.
Materials and Methods
Culture of Undifferentiated hES Cells
H1 and H9 hES cells were obtained from Wicell (Madison, WI).
hES cells were maintained on irradiated mouse embryonic
fibroblasts (MEFs) at 5% CO2 in medium containing Knockout-
Dulbecco’s modified Eagle medium (KO-DMEM), 20% serum
replacement, 1% nonessential amino acids, 1 mM L-glutamine,
0.1 mM β-mercaptoethanol, and 4 ng/ml fibroblast growth factor-2
(FGF-2; GIBCO BRL). The cells were passaged in a 4-day cycle by
incubating with 1 mg/ml collagenase IV at 37°C for 45 min,
maintaining the cells in small clumps. To avoid contamination by
MEFs in the transfection (liposome, electroporation, nucleofection)
analysis, the hES cells were cultured on Matrigel in MEF-
conditioned medium for one passage prior to transfection. Approx-
imately, 2×10
4/cm
2 cells were plated uniformly in six-well plates
prior to transfection. Samples of the cells were immunostained with
anti-SSEA-4 (Chemicon, Temecula, CA) and anti-Oct-4 (Santa Cruz
Biotechnology, Santa Cruz, CA) antibodies. Immunofluorescent
labeling was analyzed using a Zeiss LSM 510 Confocal Laser
Scanning Microscope equipped with a Coherent Mira 900 tunable Ti:
sapphire laser for two-photon excitation (Zeiss, Minneapolis, MN).
Construction of pUb-eGFP-Fluc and pUb-eGFP-
Fluc-SV40-neomycin
The pUb-eGFP-Fluc construct used for lentiviral transduction has
been described previously [18]. The pUb-eGFP-Fluc-SV40-
neomycin was generated by cleaving pUb-GFP-Fluc at the BamH1
restriction enzymes and blunt-end ligating the SV40-neomycin
construct. This plasmid was used for stable transfection of hES
cells using neomycin as a selection marker.
Plasmid Transfection Methods
(a) Lipofection: lipofection was performed 1 day after plating H1 and H9
hES cells (4–5×10
5/well) onto Matrigel at a confluency of 60–70%.
Qiagen lipofection 2000 was used according to the manufacturer’s
protocol. Briefly, 5μg of plasmid DNA (pUb-eGFP-Fluc) was diluted in
250μl of KO-DMEM followed by addition of 10μl of liposomal reagent.
The mixture was incubated for 15–20 min at room temperature. The
mixture was then added to 1,000μl of pre-warmed conditioned medium
and transferred to one well of a six-well plates. (b) Electroporation: 5μg
of plasmid DNA (pUb-eGFP-Fluc) was diluted in 500μl of phosphate-
buffered saline (PBS) and added to 4–5×10
5 hES H1 and H9 cells
suspended in 500μl of hES culture medium. Electroporation was
performed in a 4-mm gap cuvette using a Gene Pulser (BioRad,
München,Germany)withthe electric parameterssetat300 Vand220μF.
After pulsing, the cells were incubated in the cuvette at room temperature
for 10 min. The cells were transfer r e dt on e wm e d i u ma n dp l a t e do n t o
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5 cells/cm
2.
Each plate was analyzed for eGFP expression under a fluorescence
microscope at 24, 48, and 72 h post-electroporation. (c) Nucleofection:
4-5×10
5hES H1 and H9 cells were centrifuged for 5 min at 800 rpm and
4°C. The culture medium was removed and cells were resuspended in
100μl of the nucleofector solution (Amaxa Biosystems, Cologne,
Germany). DNA (5μg) was added, cells and DNA were gently mixed,
and cells were electroporated using the Nucleofector™ device (Amaxa
Biosystems). Transfections were performed with a program (A23) that
was selected in a series of pilot transfection experiments with the eGFP
reporter gene and proven to result in the highest transfection efficiency.
Directly after transfection, hES cells were placed into the culture medium.
Lentiviral Vector Preparation and Transduction
A self-inactivating lentivirus was prepared by transient transfection
of 293 T cells as described previously [16, 19]. Briefly, 12µg of the
HIV-1 packaging plasmid (peGFP-Fluc/pRRE; delta-8.9) contain-
ing the eGFP-Fluc reporter gene were cotransfected into 293 T cells
with 9µg of vesicular stomatitis virus G glycoprotein-pseudotyped
envelope vector (pVSV-G), and 6.25µg of REV plasmid (pRSV-
REV). Lentivirus supernatant was collected after 72 h and
concentrated by sediment centrifugation with SW29 rotor at
50,000×g for 2 hours. Concentrated virus was titrated on 293 T
cells. hES H1 and H9 cells (4–5×10
5) were incubated with virus
particles at MOI of 10 and 8µg/ml polybrene (Sigma). The media
was changed after 12 h by fresh medium.
Generation of Stable Cell Line
Stable hES cell lines were generated by fluorescence-activated cell
sorting (FACS) in the lentiviral transduction group and by G418
selection (50–100µg/ml) over 2 weeks in the nucleofection group.
Colonies were isolated, propagated, and analyzed for eGFP
expression and Fluc activity.
Cell Viability Analysis
Cell viability was determined using dissociated cells prior to
plating, as well as at 24 and 48 h after transfection. Viability was
measured using trypan blue exclusion and expressed as a
percentage of the initial number of cells used for each transfection.
Immunohistochemistry
The H1 and H9 hES cells treated with the various transfection
protocols were plated onto cover slips within six-well plates, fixed
in 5% paraformaldehyde for 1 min, and blocked with 1% bovine
serum albumin in PBS. They were incubated with the primary
antibody in PBS at 37°C for 1 h, followed by several PBS washes,
and incubation with a secondary antibody at 37°C for 1 h, with
final PBS washes. Slides were mounted with Vectorshield (Vector
Laboratories, Inc., Burlingame, CA, USA).
Fluorescence-activated Cell Sorter Analysis
Twenty-four hours after transfection, the cells were washed twice
with KO-DMEM and dissociated with Accutase II. After centrifu-
gation, the cells were resuspended at 1×10
6 cells/ml in PBS and
stored on ice for a maximum of 1 h before analysis. Acquisition
was performed on a FACS Calibur system (BD Biosciences,
Heidelberg, Germany) and samples were analyzed using FlowJo
software (Tree Star Inc., Ashland, OR). Analysis-gating criteria for
eGFP-expressing cells were set according to the level of auto-
fluorescence of a non-transfected control.
Transplantation of hES Cells into Nude Mice
Harvested control hES and stable hES-DF cells (transduced with
lentivirus) were kept on ice for G30 min for optimal viability. Adult
immunodeficient nu/nu mice (n=5) were injected subcutaneously
with 1×10
6 hES-DF cells in 50µL of PBS. Control animals (n=3)
received 1×10
6 non-transduced hES cells. All animals had an
uneventful recovery and underwent bioluminescence imaging at
various time points. Study protocols were approved by the Stanford
Animal Research Committee.
Optical Bioluminescence Imaging of hES Cell
Transplantation
Bioluminescence imaging was performed with the Xenogen In Vivo
Imaging System (IVIS, Alameda, CA). Following intraperitoneal
injection of the reporter probe D-luciferin (375 mg/kg body weight),
animals were imaged for 30 min with 1-min acquisition intervals. The
same mice were scanned at various time points for a 6-week period
according to the specific study design. Bioluminescence was
quantified in units of maximum photons per second per centimeter
squared per steradian (P s
−1 cm
−2 sr
−1), as described previously [18].
Statistical Analysis
Quantitative data were expressed as mean±SD. Means were
compared using one-way ANOVA and the Student t test. P values
of less than 0.05 were considered statistically significant.
Results
hES Cells Maintained on a Feeder-free Culture
System Express Stem Cell Markers
Previous studies have detailed the need to separate hES cells
from contaminant feeder layer cells prior to the initiation of
studies [20]. For our studies, the H9 and H1 cells were
reseeded onto Matrigel-coated plates to eliminate any
possible contaminating effects of the MEF feeder layer.
Additional studies were performed on these hES cells to
confirm that separation from the feeder layer had not
changed the basic characteristics of the cells. The cell
doubling time was tested by cell counting, which revealed
similar results between the hES cells on feeder layer and
feeder-free plates (37±3.4 h vs. 36±2.1 h; P=NS). The two
cell lines showed the same morphology under brightfield
microscopy (Fig. 1). Immunohistochemistry staining also
showed similar expression pattern of Oct-4 and SSEA-4
under fluorescence microscopy for H9 and H1 hES cells.
These results confirm that H9 and H1 hES cells grown in a
feeder-free cell culture system maintained similar growth
and surface marker expression characteristics compared to
hES cells grown on conventional feeder layers.
F. Cao et al.: Gene-Transfer Efficiency in Human Embryonic Stem Cells 17Lentivirus transduction and Plasmid Nucleofection
Demonstrate Higher Efficiencies in vitro
Following a review of the literature (previously detailed)
[11, 21–23], transfection conditions yielding the highest
efficiencies for hES cells were utilized for each transfec-
tion protocol. Within 24 h, there was a significant
difference in gene-transfer efficiencies in H9 and H1
cells. In particular, lentiviral transduction demonstrated
the highest level of Fluc gene expression, with biolumi-
nescence measurements of 0.95±0.13×10
6 photons/s for
H9 and 1.37±0.16×10
6 for H1. Nucleofection demon-
strated lower transfection efficiency compared to lenti-
viral transduction (3.2±3.9×10
5 photons/s for H9 and
5.6±0.12×10
5 for H1; PG0.05 for both). Importantly,
both electroporation and lipofection had very low
transfection efficiencies compared to lentiviral transduc-
tion and nucleofection (Fig. 2). In our studies, the H1
cell line had higher transfection efficiency than the H9
hES cell line for all protocols tested, suggesting varying
susceptibility to gene transfer in different hES lines.
FACS Analysis of eGFP Expression in H1 and H9
hES Cell Lines
The double-fusion construct allows us to simultaneously
analyze eGFP by FACS and Fluc by bioluminescence
imaging. Consistent with the Fluc bioluminescence activity
shown above, the eGFP expression was highest in lentiviral-
transduced cells followed by nucleofection-transfected cells
(Fig. 3). Lentiviral transduction demonstrated the highest
transduction efficiency, with 25.3±4.8% and 22.4±6.5%
positive eGFP cells for H1 and H9, respectively. Nucleo-
fection demonstrated transfection efficiency of 16.1±3.6%
(H1) and 5.8±3.2% (H9). Low eGFP expression was again
seen in electroporation (2.1±0.4% (H1) and 1.9±0.3% (H9))
and lipofection (1.5±0.5% (H1) and 1.3±0.2% (H9)).
Higher Cell Viability Demonstrated
in lentiviral-transduced Cells
The protocols and expertise to isolate and grow sufficient
quantities of hES cells are complex and technically
challenging. Due to this laborious process, a high hES cell
viability following gene transfer is essential. It is commonly
known that electroporation of hES cells results in significant
cell death, despite efforts to optimize and minimize the
energy delivered [9]. The use of lentivirus, on the other
hand, has previously demonstrated high levels of cell
viability following transduction [16, 17]. To address this
issue, we examined the cell morphology and assessed the
cell viability using trypan blue exclusion at 24 h following
gene transfer with the various protocols. The H1 and H9
cells were examined by overlaying brightfield microscopy
with eGFP fluorescence. H9 cells clearly demonstrate
significantly lower viability in electroporation treated cells
(Fig. 4), followed by nucleofection-treated cells. Similar
results were obtained for H1 cells (data not shown). The
trypan blue assay details the cell viability following electro-
H9
H1
Brightfield Oct4 SSEA4  
Fig. 1. Immunohistochemistry of stem cell markers on undifferentiated H9 and H1 cell lines grown in feeder-cell free cultures in
vitro. H9 and H1 cells were reseeded onto Matrigel-coated plates. Brightfield and immunohistochemistry staining with
fluorescence microscopy for Oct-4 and SSEA-4 stem cell markers was performed. DAPI staining is used as a nuclear marker
(scale bar=50µm in mid- and right fluorescence staining; 200µm in left brightfield).
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nucleofection at 25±9% (H1) and 30±15% (H9) at 24 h. By
contrast, the other four groups all showed greater than 95%
viability.
In vivo Imaging to Monitor hES Cell Survival,
Proliferation, and Teratoma Formation
The ability to monitor transplanted hES cells in vivo without
sacrificing the animals has been made possible by incorpo-
rating newer imaging technologies such as optical biolumi-
nescence or positron-emission tomography [24]. Following
subcutaneous transplantation, bioluminescence imaging was
performed on days 2, 7, 14, 35, 42, and 56 (Fig. 5a). H9-DF
cells (via stable lentiviral transduction) showed persistent
engraftment and survival as measured by bioluminescence
activities: day 2 (55.2±14.3×10
6), day 7 (21.2±6.1×10
6), day
14 (17.2±5.0×10
6), day 35 (19.5±3.2×10
6), day 42 (28.1±
7.2×10
6), and day 56 (65.3±14.1×10
6p/s/cm
2/sr). Control H9
cells (not expressing the GFP-Fluc) cannot be detected as
expected. Following imaging at day 56, animals were
sacrificed and the teratoma explanted. Histologic analysis of
control hES and hES-DF teratomas shows mixed regions of
endodermal, mesodermal, and ectodermal differentiation
(Fig. 5b). Thus, the histological data suggest that lentiviral
transduction did not significantly affect the differentiation of
hES cells into the three germ layer cell types in vivo.
Discussion
To date, the ability to manipulate stem cells for clinical
applications has been limited by techniques in basic molecular
and cellular biology, as well as our understanding of ES cell
biology. Protocols for gene transfer that had demonstrated
significant promise in mouse embryonic stem (mES) cells,
suchaselectroporationandlipofection,are lessefficientinhES
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Fig. 2. Transfection and transduction of H9 and H1 hES cells in vitro with each of the transfection protocols. (a) H9 and H1
cells were seeded onto feeder-cell free Matrigel-coated six-well plates after transfection with plasmid alone (Plasmid),
lipofection (Lipo+P), electroporation (Electro+P), nucleofection (Nucleo+P), and transduction with lentivirus (LentiV). (b) The cells
were examined using bioluminescence imaging of Fluc activities after transfection. The quantitative measurements are shown
24 h after gene delivery.
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levels of transfection efficiency, whereas hES cells are
notoriously difficult to transfect. This has led to optimizing
existing protocols, as well as the discovery of novel and
cutting-edge techniques that have increased transfection
efficiency into hES cells. It is important that if these protocols
aretobeusedroutinelyasanefficient,simple,andreproducible
method of gene transfer, the effect on hES cell growth and
differentiationshouldnotbeaffected,andtransgeneexpression
should remain intact over prolonged periods of time. Using a
double-fusion reporter gene that allows for non-invasive “real-
time” imaging, we have examined the transfection and
transduction efficiency of various protocols on the H1 and
H9 hES cell lines in vitro and in vivo.
Few studies have performed side-by-side comparison of
the efficiency of the various transfection and transduction
methods available for gene transfer to hES cells. Nucleofec-
tion of hES cells has shown superior transfection efficiency
compared to lipofection and electroporation for H9.2 cells
[11], and in adipose-tissue-derived stem cells [21]. We have
examined the protocols from these studies, as well as
numerous other studies to identify the optimal experimental
conditions for electroporation, lipofection, nucleofection, and
lentiviral transduction using male H1 and female H9 cells,
and have compared their transfection or transduction efficien-
cy in vitro. The double-fusion construct (expressing eGFP and
the Fluc) allowed for rapid, reproducible, and real-time
monitoring of cells over an extended period of time.
Lentiviral transduction demonstrated the highest level of gene
transfer (22–25%) with the best viability following treatment
(>95%). The highest efficiency using a non-viral protocol was
demonstrated by nucleofection, though with a mildly de-
creased level of viability (70–75%). Electroporation and
lipofection demonstrated very low levels of transfection
efficiency, which is consistent with previous studies reported
[23]. Viability following treatment with electroporation was
poor (20–25%) despite attempts to optimize the specific
voltage and capacity settings. For each modality, expression
of the eGFP-Fluc double-fusion reporter gene did not appear
to affect cell growth and viability.
Fig. 3. Measurement of eGFP expression using flow cytometry analysis of H1 and H9 hES cell lines transfected with each
protocol. The bi-fusion pUb-eGFP-Fluc construct was transfected into H9 and H1 hES cells using lipofection (Lipo+P),
electroporation (Electro+P), nucleofection (Nucleo+P), and transduction with lentivirus (LentiV). eGFP expression was measured
using FACS analysis.
20 F. Cao et al.: Gene-Transfer Efficiency in Human Embryonic Stem CellsPrevious studies have examined transient transfection of
various hES cell lines in vitro, and production of stable
human ES cell lines [16, 23, 25]. However, few studies have
generated stable hES cell lines and monitored their growth in
vivo using noninvasive bioluminescence imaging. In this
study, we have also generated stable cell lines with lentiviral
transduction and plasmid nucleofection protocols using the
double-fusion (DF) reporter gene construct and monitored
their growth and differentiation in vivo over several months.
Immunofluorescence and histological analysis demonstrates
that the stable hES cell lines consist of undifferentiated cells
that express numerous stem cell markers, including SSEA4
and Oct4. After several weeks, these undifferentiated cells
develop into subcutaneous teratomas. In addition, the DF
reporter gene did not affect hES cell viability, growth, and
differentiation, similar to previous report on mES cells [24].
Of note, the higher number of stable cell lines (~twofold
higher) generated by lentiviral transduction compared to
nucleofection is likely secondary to a higher gene-transfer
rate, in combination with a higher rate of viability.
Transfection and transduction protocols that can success-
fully transfer genes to the nucleus in a cell-cycle-indepen-
dent manner will be most effective in hES cells. Lipofection
(including Fugene and Exgen 500), transduction with many
pseudotyped retroviral constructs (e.g., murine leukemia
virus), and polymer- or polycation-based protocols require
cell proliferation (mitosis) and breakdown of the nuclear
envelope, or nuclear localization signal (NLS) directing
transport from the cytoplasm to the nucleus. The trafficking
of gene products to the nucleus has been challenging, with
mixed success using well-characterized NLS signals, such as
the SV40 NLS for example [26–28]. By contrast, lentivirus,
adenovirus, and AAV can infect both dividing and non-
dividing cells, have low cytogenicity, and can integrate their
genome into the host chromosome. The use of vectors
derived from retroviruses as gene-transfer vehicles in this
setting has had limited success because of silencing of
transgene expression. Two major mechanisms have been
identified for retrovirus silencing: trans-acting factors that
bind to the viral promoters in the long terminal repeats
(LTRs) and methylation of the integrated retroviral genome
and flanking host DNA sequences [29]. Similar to the
lentiviral system, electroporation is independent of cell cycle
and can directly transport DNA to the nucleus. Despite
efforts to optimize the specific voltage and capacity settings,
survival rates and levels of transfection efficiency in hES
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Fig. 4. Viability of H9 and H1 hES cells in vitro following transfection with the various gene-transfer protocols. H9 and H1 hES
cells were examined at 24 h following transfection with lipofection (Lipo+P), electroporation (Electro+P), nucleofection (Nucleo+P)
andtransductionwithlentivirus(LentiV).Cellmorphologyandtrypanblueexclusionassaywasperformedtomeasurecellviability.
(a) Fluorescence microscopy of representative H1 cells. Scale bar=100µm. (b) Viability of each transfected cell lines at 24 h as
measured using the trypan blue assay.
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Fig. 5. Optical bioluminescence imaging of stably expressed hES cells in vivo over time, with demonstration of proliferation
and teratoma formation. The pUb-eGFP-Fluc-SV40-Puro construct was stably expressed in H9 cells by transduction with
replication-incompetent lentivirus. Stable colonies (hES-DF) were selected by drug selection over 2 weeks and then injected
subcutaneously into right shoulder of nude mice. Control untransduced H9 hES cells were injected into left shoulder. (a) In vivo
bioluminescence imaging of the hES-DF cells on days 2, 7, 14, 35, 42, and 56. (b) Histology of the H9 hES cells stably
expressing eGFP-Fluc in nude mice were examined through 56 days. Teratoma formation was demonstrated by histology at
week 8 weeks after subcutaneous injection: (A) rosette consistent with neuroectodermal differentiation (ectoderm), (B) cartilage
formation (mesoderm), (C) respiratory epithelium with ciliated columnar, and (D) mucin-producing goblet cells (endoderm)
surrounded with mesenchymal cells (mesoderm). Scale bar=50µm.
22 F. Cao et al.: Gene-Transfer Efficiency in Human Embryonic Stem Cellscells have been poor. Nucleofection, on the other hand, has
demonstrated higher levels of transfection efficiency with
significantly improved levels of cell viability over electro-
poration. This technique has demonstrated the ability to
ubiquitously transfect various cell lines [30, 31], including
CD34
+ cells and H1 cells [14]. In this study, the nucleo-
fector settings and buffer were selected based on previous
studies in our lab, as well as other published reports [27, 28].
The ability to adapt the nucleofection parameters and buffers
to various primary cell lines may further improve transfec-
tion efficiency. In addition, other studies using nucleofection
have demonstrated efficient expression of siRNA [32],
mRNA [22, 33], and various small and macromolecules [9].
In this study, both lentiviral transduction and plasmid
nucleofection protocols successfully generated stable hES
clones that stably expressed the DF reporter gene. Although
lentivirus generated higher numbers of stable clones,
nucleofection is a simple, reproducible, and efficient
technique for transient as well as stable transfection. The
double-fusion construct allowed for effective, non-invasive
tracking of proliferating hES cells in nude mice, with no
noticeable disruption of cell differentiation during prolonged
gene expression. The lack of significant transgene silencing
following in vivo transplantation has been previously
reported [24].
In summary, the ability to study the biology of hES cells
requires genetic manipulation to express various transgenes.
Nucleofection is an attractive transfection protocol with
minimal safety concerns. It is a simple and efficient system
and can be used to generate hES cell lines stably expressing
reporter genes. Although this protocol can generate stable
hES cell lines, the lentiviral system is more efficient and
could still play a role in various applications.
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